The discovery of the calcium-sensing receptor (CaSR) and the development of calcimimetics have provided new insights into calcium homeostasis and new therapeutic opportunities for parathyroid-related disorders. However, the CaSR is also implicated in various other cellular processes, and the translational applications of calcimimetics may not be exclusively calcium-centric. Koleganova et al. describe a novel role for calcimimetics as vasculotropes, which provides the impetus for further studies to characterize their effects on vascular biology.
CITATION STYLE
Al-Aly, Z. (2009). The new role of calcimimetics as vasculotropic agents. Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2008.563
Mendeley helps you to discover research relevant for your work.